Navigation Links
Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)
Date:2/11/2009

uld prove to be lifesaving for these patients. With this add-on therapy, we believe existing devices would not only be able to treat seizures but also prevent SUDEP that would result from respiratory dysfunction of failure", said Mr. Kameli. He further said: "The body of knowledge in post mortem analysis of these deaths suggests that abnormal respiratory patterns during seizure may have led to an unrecoverable condition possibly causing death".

As Victhom develops its scientific knowledge in the field of respiration and respiratory disorders, it continues to discover new and novel approaches to treat various conditions using its neuromodulation technology for detection and treatment. The current patent application is another sign of continued progress in this field.

With the recent CE Mark approval of the Neurostep(TM) System, Victhom is focused on the plans to introduce that product to the European market late 2009. Further developments in apnea and respiratory therapy will continue at the research level. Victhom plans in partnering with leaders in the field of epilepsy treatment to complete the development and introduction of this therapy to the market.

About Victhom Human Bionics

Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom's Neurobionix division focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom's Biotronix division develops biomechatronic products to support or replace peripheral limbs in what is known as the orthotics and prosthetics market.

Forward-Looking Statements

Some of the statements made herein may constitute forward-looking statements. These statements relate to future events or our future financial per
'/>"/>

SOURCE VICTHOM HUMAN BIONICS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Victhom Human Bionics Receives CE Mark for the Neurostep(TM) System, the Worlds First Fully Implantable Closed-Loop Neuromodulation Therapy for Treatment of Foot Drop
2. Victhom Human Bionics Neurobionix Division receives ISO 13485:2003 Certification for its Design Control System
3. Victhom announces the completion of the second phase of the apnea therapy development
4. Victhom Announces Launch of Enhanced Company Website
5. Victhom to Participate in the OneMedPlace Finance Forum
6. Victhom announces promising results on the proof of concept for its unique closed-loop neuromodulation system
7. China Pharma Holdings, Inc. Announces Clinical Trials Already Underway for Candesartan
8. Advanced Life Sciences Announces 2008 Fourth Quarter and Full Year Financial Results
9. Zeus Announces Product Name Changes
10. SciQuest Announces Strategic Alliance with Ceiba Solutions
11. On Third Anniversary, Compendia Bioscience Announces Continued Revenue Growth, Major Long-Term Customer Contracts and Forecasts Profitability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Maryland (PRWEB) May 20, 2013 In ... in the field of biotoxin related illnesses , announced ... the country able to advance his protocol for treating ... Patel became the third physician to achieve certification in ... Certified Physicians, able to practice the Shoemaker Protocol in ...
(Date:5/17/2013)... NY (PRWEB) May 17, 2013 ... Topical BioMedics, Inc., has been listed among nationally ... in an initiative conducted by "U.S. News" Health ... has earned the “No. 1 Pharmacists Recommended ... 17 other national OTC brands, and is the ...
(Date:5/17/2013)... is available in German . ... with the naked eye, you can see which branch a ... blur of branches through the telephoto lens for high-magnification images ... who are looking to study proteins, the active biomolecules of ... Institute for Molecular Systems Biology, and her colleagues have now ...
(Date:5/17/2013)... , May 17, 2013 ... by the most innovative thought leaders of the ... & Manufacturing East conference and expo, from June ...      (Photo: http://photos.prnewswire.com/prnh/20130517/613829 ) , ... designed to deliver industry professionals practical presentations and ...
Breaking Biology Technology:Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3MedTech Innovate Seminars: New Interactive Learning Forums at 2013 MD&M East 2
... May 16, 2012  Questcor Pharmaceuticals, Inc. (NASDAQ: ... has increased the Company,s common share repurchase program authorization ... the beginning of 2008, the Company has returned $236 ... million common and preferred shares, representing approximately 27% of ...
... WOONSOCKET, R.I., May 16, 2012  MultiCell Technologies, Inc. ... pleased to announce representatives from the Company will ... at CIMT 2012 ( http://meeting.cimt.eu ), Europe,s largest ... CIMT 2012 will be held in May 23-25 ...
... taken a step toward overcoming a key obstacle ... optical advances including ultrapowerful microscopes, computers and solar ... create the metamaterials without the traditional silver or ... University assistant professor of electrical and computer engineering. ...
Cached Biology Technology:Questcor Pharmaceuticals Expands Repurchase Program 2Questcor Pharmaceuticals Expands Repurchase Program 3Questcor Pharmaceuticals Expands Repurchase Program 4Questcor Pharmaceuticals Expands Repurchase Program 5MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 2MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 3MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 4MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 5New 'metamaterial' practical for optical advances 2New 'metamaterial' practical for optical advances 3
(Date:5/16/2013)... fast food restaurant had a higher body mass index ... food, according to researchers at The University of Texas ... strong among those with a lower income. , ... Journal of Public Health indicates higher BMI associates ... among lower-income African-Americans, the density, or number, of fast ...
(Date:5/16/2013)... PA, May 16, 2013 The relationship between ... (IQ) has not been clear. Schizophrenia is commonly ... disability. There are clues that reduced IQ may ... For example, reduced cognitive ability may precede the ... be present in healthy relatives of people diagnosed ...
(Date:5/16/2013)... the bone marrow in the liver, the spleen ... show that a specific type of immune cell facilitates ... hematopoiesis is essential for the function of the immune ... the liver and the spleen. Later the process is ... serves as the sole source of blood cells for ...
Breaking Biology News(10 mins):Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3Genetic risk for schizophrenia is connected to reduced IQ 2Herpes infections: Natural killer cells activate hematopoiesis 2
... is a growing human health concern. Researchers around ... to be present in surface waters and sediments, ... In a recent article in the November-December issue ... State University (CSU) describe a study to find ...
... morality gives but a slight or no advantage to ... men of the same tribe...an advancement in the standard ... one tribe over another. With these ... and pro-social behaviors individuals behaving for the good of ...
... Britain over the past 17 years for extracting oil is ... heavy oilfield in Canada. Duvernay Petroleum is to ... the University of Bath at its site at Peace River ... is very viscous, like syrup, or even solid in its ...
Cached Biology News:Manure management reduces levels of antibiotics and antibiotic resistance genes 2Group selection, a theory whose time has come...again 2Massive Canadian oilfield could be exploited using new UK system 2Massive Canadian oilfield could be exploited using new UK system 3
Provides continuous mixing action. For use with tubes, vials, and other containers...
Agarose for baculovirus plaque assays which allow optimal growth of plated insect cells....
These disposable button tethers are designed for rat infusion studies lasting more than 2 weeks. After one to two weeks the subcutaneous tissue will grow into the Dacron mesh, making the sutures irre...
Mycoplasma and virus tested...
Biology Products: